Medicines4Kids In the Open
In the News: Six-year-old’s death leads to hope of new drug for childhood cancer
Our collaborator Dr Chris Jones and his fantastic team at The Institute of Cancer Research were profiled in The Observer for their work on DIPG with support from Abbie's Army. [...]
Recording of M4K Pharma’s Scientific Update Meeting – October 2nd, 2019
Listen to a recording of the October Monthly Scientific Meeting Listen to M4K Pharma's Scientific Update Meeting from October 2nd, 2019 where our scientists and collaborators discuss [...]
Poster award for CRL and M4K open science collaboration
Poster award for CRL and M4K open science collaboration Congratulations to Senior Scientist Stefano Levanto from Charles River Laboratories (CRL) on winning the early career poster prize for his poster [...]
SGC-Oxford team comes out in support of Brain Tumour Charity’s Twilight Walk
SGC-Oxford team comes out in support of Brain Tumour Charity's Twilight Walk On September 29th 2019, the Brain Tumour Charity organized The Twilight Walk in Warwick, UK, to raise funds [...]
Collaborators share first ALK2 protein structure bound to M4K Pharma compound
Collaborators share first ALK2 protein structure bound to M4K Pharma compound A: The overall structure of ALK2 bound to M4K2117. B: The structure of the ligand M4K2117. C: A close [...]
Fostering open collaboration in drug development for paediatric brain tumours
Fostering open collaboration in drug development for paediatric brain tumours Wong et al. describe in Biochemical Society Transactions how open collaboration and an open drug discovery model, like the one [...]